A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
Table 3
Hematological toxicities1.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Hematological toxicities1.